A Dose Escalation Study of IBI324 in Subjects With Diabetic Macular Edema

Clinical trial NCT05489718 · COMPLETED

Trial details

NCT number: NCT05489718
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetic Macular Edema

Start date: 2022-08-01
Primary completion: 2023-06-05
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.